develops, produces, and markets drugs or pharmaceuticals licensed for use as medications
Trump says US could stay in Iran and keep oil, like Venezuela deal: He drew a parallel with the U.S. push to take control of a fifth of Venezuela's reserves.
reuters.com/business/energy/trump-says-us-could-stay-iran-keep-oil-like-venezuela-deal-2026-09-13/
An emotional Shane Lowry reflects on his record-breaking win at the Amgen Irish Open! ☘️
Major Novartis shareholder calls for board shake-up after drug trial setbacks: A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's ...
reuters.com/world/major-novartis-shareholder-calls-board-shake-up-after-drug-trial-setbacks-2026-09-10/
Novartis investors turn spotlight on M&A after trial setbacks: Novartis investors are set to step up scrutiny of the Swiss group's dealmaking strategy after ...
reuters.com/legal/transactional/novartis-investors-turn-spotlight-ma-after-trial-setbacks-2026-09-11/
S&P Dow Jones Indices loosens Canadian index inclusion criteria: S&P Dow Jones Indices (S&P DJI) said on Friday it will change the eligibility criteria for ...
reuters.com/world/americas/sp-dow-jones-indices-loosens-canadian-index-inclusion-criteria-2026-09-13/
Pensioner left distressed after double MSD botch-up: Pensioner left distressed after double MSD botch-up
odt.co.nz/news/national/pensioner-left-distressed-after-double-msd-botch-up-u3t2juxa
The Lancet: New US Medicare pricing policies could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches ...
eurekalert.org/news-releases/1143512
Incumbent Rhode Island governor projected to lose Democratic primary to former CVS executive
cbsnews.com/news/rhode-island-governor-race-results-helena-foulkes-dan-mckee/
Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share
cnbc.com/2026/09/14/novo-nordisk-rebrands-to-novo-ceo-mike-doustdar.html
Ozempic-maker Novo Nordisk slims down to ‘Novo’: Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy ...
ctvnews.ca/business/article/ozempic-maker-novo-nordisk-slims-down-to-novo/
Dresden: Pharmaceutical company GSK plans to close vaccine plant - | 641 jobs threatened
dnn.de/lokales/dresden/dresden-pharmakonzern-gsk-will-impfstoffwerk-schliessen-641-jobs-bedroht-T7AQRYHS4VAY7MIUHYC7Q4EPGI.html
OpinionThe Week in Breakingviews: Wall Street’s new gods: Firms like Apollo Global Management have elbowed their way into territory previously patrolled by big banks ...
reuters.com/commentary/breakingviews/global-markets-breakingviews-2026-09-12/
Trump says US can 'easily' afford $1.2T price tag for $5K dividend to adults: President Donald Trump doubled down on his $5,000 dividend pledge at the Amgen ...
foxbusiness.com/politics/trump-says-us-can-easily-afford-1-2t-price-tag-5k-dividend-adults
Young people with HIV (PWH) who received an electronic monitoring device (EMD) — a digital pillbox that logs medication openings in real time and triggers text ... Show more
Novartis stock sinks toward worst day ever after third drug trial failure in a week
qz.com/novartis-del-desiran-trial-failure-stock-090826
Donald Trump has landed at the Amgen Irish Open, the US president touching down in his Marine One helicopter just before 3pm and sweeping into the hotel ... Show more
OpinionIt’s time for AI labs to take a drug test: Tech moguls’ “move fast and break things” ethos is a bad fit for chatbots posing catastrophic risks ...
reuters.com/commentary/breakingviews/its-time-ai-labs-take-drug-test-2026-09-11/
Morgan Stanley downgrades Novo Nordisk $NVO to Underweight citing heavy reliance on blockbuster drug Semaglutide!
KEY HIGHLIGHTS:
• Semaglutide expected to ... Show more
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at ...
edition.cnn.com/2026/08/21/health/mrna-cancer-vaccines-wave
CNBC Sep 09
Novartis CEO on drug trial setbacks: We have the pipeline and replacement power to grow
cnbc.com/video/2026/09/09/novartis-ceo-on-drug-trial-setbacks-we-have-the-pipeline-and-replacement-power-to-grow.html
‘Indian farmer should not be deprived of any technology,’ Q&A with Simon Wiebusch, managing director and CEO, Bayer Crop Science
financialexpress.com/policy/economy-indian-farmer-should-not-be-deprived-of-any-technology-qa-with-simon-wiebusch-managing-director-and-ceo-bayer-crop-science-4335522/
Novartis India buys Minipress brands from Pfizer for ₹1,250 crore: The company's board approved the transaction on Monday, following which Novartis India ...
business-standard.com/companies/news/novartis-india-buys-minipress-brands-from-pfizer-for-1-250-crore-126090700955_1.html
Bayer's $7.25 billion Roundup settlement faces final approval test in Missouri court
qz.com/bayer-roundup-settlement-final-approval-hearing-091126
Indian pharma market grows 10.7% in August despite 3-month volume low: Pharma sales value rose to Rs 23,272 crore in August, driven by new introductions and ...
business-standard.com/industry/news/indian-pharma-market-grows-10-7-in-august-despite-3-month-volume-low-126090701384_1.html
AstraZeneca's experimental COPD drug aced late-stage trials, boosting blockbuster sales hopes
qz.com/astrazeneca-tozorakimab-copd-phase-3-trials-090826
Sun Pharma secures over two-year relief from US pharma tariffs; pact signed with US govt to provide affordable drugs
financialexpress.com/business/industry-sun-pharma-secures-over-two-year-relief-from-us-pharma-tariffs-pact-signed-with-us-govt-to-provide-affordable-drugs-4329881/
Multiple myeloma: A cure in sight?: In Austria, approximately 2,500 people are affected by multiple myeloma*. For this disease, which used to be almost a death ...
diepresse.com/38640598/multiples-myelom-heilung-in-sicht
Bayer bets big on climate-resilient crops: Commercial cultivation of genome-edited corn, soya likely in 5 years
financialexpress.com/policy/economy/bayer-betsbigon-climate-resilient-crops/4333050/
Why Dark Manicures Should Be Worn in the Summer: Long live the dark manicure. No heat wave will make me quit OPI's Lincoln Park After Dark and other "winter" ...
allure.com/story/dark-manicure-summer-nails
SC sends Vedanta buyback fraud case back to SAT for fresh examination: The Supreme Court asked SAT to reconsider Sebi's fraud allegations against Vedanta ...
business-standard.com/india-news/sc-sends-vedanta-buyback-fraud-case-back-to-sat-for-fresh-examination-126090901463_1.html
GOP’s Mike Minogue to spend up to $2 billion on campaign to unseat Gov. Healey: GOP gubernatorial candidate Mike Minogue plans to spend up to $2 billion on his ...
bostonherald.com/2026/09/06/gops-mike-minogue-to-spend-up-to-2-billion-on-campaign-to-unseat-gov-healey/
Stocks to watch: Sun Pharma, Suzlon Energy, OMCs, Biocon, IHCL, Tata Power: Stocks to watch: Sun Pharma, Suzlon Energy, OMCs, Biocon, IHCL, Tata Power, TCS ...
business-standard.com/markets/news/stocks-to-watch-sun-pharma-suzlon-energy-omcs-biocon-ihcl-tata-power-126090900126_1.html
Novo Nordisk says semaglutide cut obesity rates in young children in trial: Novo Nordisk said on Monday that in a late-stage trial, 40.4 per cent of children ...
ctvnews.ca/health/article/novo-nordisk-says-semaglutide-cut-obesity-rates-in-young-children-in-trial/
CNBC Sep 09
Anthropic has the right mindset when it comes to AI safety, says board Member Vas Narasimhan
cnbc.com/video/2026/09/09/anthropic-has-the-right-mindset-when-it-comes-to-ai-safety-says-board-member-vas-narasimhan.html
Mounjaro sales soar 502% as India's GLP-1 drug market expands rapidly: Mounjaro Sales in India: Mounjaro has overtaken other GLP-1 medicines to become India's ...
business-standard.com/health/mounjaro-sales-soar-502-as-india-s-glp-1-drug-market-expands-rapidly-126091000479_1.html
CNBC Sep 09
Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growth
cnbc.com/video/2026/09/09/biogen-ceo-we-are-at-that-inflection-point-where-we-are-on-a-path-to-sustainable-revenue-growth.html
Trump announces drug pricing deals with 9 more drugmakers: The new agreements bring the total number of companies in the administration's most-favored-nation ...
qz.com/trump-drug-pricing-deals-nine-drugmakers-083126
Biosimilars: Sandoz sets ambitious growth targets: The Basel-based generic drug manufacturer Sandoz has set ambitious growth targets. However ...
nzz.ch/wirtschaft/biosimilars-sandoz-setzt-sich-ehrgeizige-wachstumsziele-ld.10022864
Explainer: How Bharat Taxi can pick up speed: Indian benchmark indices closed near day's lows amid elevated Brent crude prices and geopolitical uncertainty ...
financialexpress.com/business/industry-explainer-how-bharat-taxi-can-pick-up-speed-4334353/
Amgen: After sharp correction - | Analyst downgrades: Amgen shares fell by over 12% after Novartis setback. HSBC downgrades to "Hold".
deraktionaer.de/artikel/pharma-biotech/amgen-nach-heftiger-korrektur-analyst-stuft-ab-20408557.html
Young people with HIV (PWH) who received an electronic monitoring device (EMD) — a digital pillbox that logs medication openings in real time and triggers text ... Show more
Top 10 stocks rated ‘Buy’ this week: Brokerages project 12% to 71% return: Track 10 brokerage ‘Buy’ calls across banking, energy, pharma and more ...
financialexpress.com/market/top-10-stocks-rated-buy-this-week-brokerages-project-12-to-71-return-4332413/
CNBC Aug 31
Eli Lilly CEO David Ricks: Acquisition of Merida will advance our goals in autoimmune diseases
cnbc.com/video/2026/08/31/eli-lilly-ceo-david-ricks-acquisition-of-merida-will-advance-our-goals-in-autoimmune-diseases.html
Lupin, Dabur among oversold stocks; analyst explains terminology, strategy: Oversold Stocks: When a stock becomes oversold, it does not automatically mean it is ...
business-standard.com/markets/news/lupin-dabur-hdfc-bank-among-32-oversold-nifty-500-stocks-analyst-explains-terminology-strategy-126091000310_1.html
yicaiglobal.com Sep 10
Novo Nordisk’s Blockbuster Weight Loss Drug Wegovy Wins China Nod for Liver Disease
yicaiglobal.com/news/novo-nordisks-blockbuster-weight-loss-drug-wegovy-wins-china-nod-for-liver-disease
India outperformance, synergy gains to keep Torrent Pharma growth strong: Strong domestic growth, a chronic-heavy portfolio, JB Pharma integration benefits and ...
business-standard.com/markets/news/india-outperformance-synergy-gains-to-keep-torrent-pharma-growth-strong-126090901485_1.html
Paid articlePaywallNovartis, Ionis' experimental heart drug misses key goal in closely watched trial
reuters.com/business/healthcare-pharmaceuticals/ionis-novartis-key-experimental-heart-drug-fails-late-stage-trial-2026-09-04/
Medicine shortages grow in Iran as US tightens sanctions, blockade: Many Iranians cannot access or afford life-saving drugs, but authorities say pharmaceutical ...
aljazeera.com/news/2026/9/9/medicine-shortages-grow-in-iran-as-us-tightens-sanctions-blockade
Novartis falls as failed cholesterol drug study raises stakes for pipeline: Shares of Novartis fell 3.3% on Monday morning after its cholesterol drug failed in a ...
reuters.com/legal/litigation/novartis-shares-down-failed-cholesterol-drug-study-increases-pipeline-pressure-2026-09-07/
Reporter Manon Gilbart speaks with local golfer Declan Griffin, Mikie Tubridy of The Yard Coffee shop and Clare County Cllr and businesswoman Rita McInerney ... Show more
Biocon wins 10-year Pertuzumab deal securing 100% allocation in Brazil: Biocon partners with Bahiafarma and Bionovis to manufacture and commercialise Pertuzumab ...
financialexpress.com/business/industry-biocon-wins-10-year-pertuzumab-deal-securing-100-allocation-in-brazil-4334101/
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk: Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to reduce the ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-lillys-mounjaro-reduce-cardiovascular-risk-2026-08-28/
MASH in the Modern Era: This educational initiative gives clinicians the tools they need to manage MASH in the modern era.
medscape.org/advances/mash-modern-era-2026a10007jk
Dividend Guarantee Novartis Under Massive Pressure After Triple Blow - | Three Takeover Targets
deraktionaer.de/artikel/pharma-biotech/dividendengarant-novartis-massiv-unter-druck-nach-dreifachem-nackenschlag-drei-uebernahmekandidaten-20408332.html
OpinionPolluter pays principle at the ECJ: Tracing the origin of toxic chemicals: The pharmaceutical | and cosmetics industries are supposed to contribute to the costs ...
taz.de/Verursacherprinzip-beim-EuGH/!6211641/
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology
reut.rs/4cobAjw
Stocks to watch: Asian Paints, Swiggy, RBL Bank, BoB & defence shares: Stocks to watch today: Bandhan Bank, defence shares, RBL Bank, PVR Inox, Adani Power ...
business-standard.com/markets/news/stocks-to-watch-asian-paints-swiggy-rbl-bank-bob-defence-shares-126090800083_1.html
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma: Novartis and Ionis' high-profile Lp(a) flop on Friday reverberated through ...
investors.com/news/technology/novartis-ionis-pharmaceuticals-heart-disease-dm1/
The Nail Color Trends of Fall 2026 Are All About Treating Yourself—See Photos: Ahead, the top nail color trends of fall 2026, according to nail artists ...
allure.com/story/fall-nail-color-trends-2026
Sun Pharma joins White House pricing pact: Agrees to MFN pricing for US Medicaid, gets 2-year tariff reprieve
financialexpress.com/business/industry-sun-pharma-joins-white-house-pricing-pact-agrees-to-mfn-pricing-for-us-medicaid-gets-2-year-tariff-reprieve-4329441/
Maharashtra FDA Commissioner Tukaram Mundhe explains his aggressive food safety drive, issuing 12,083 notices in four months ... Show more
Brazil’s black market for weight-loss drugs is booming. Smugglers are cashing in: The Friendship Bridge, connecting Brazil and Paraguay near the iconic Iguazu ...
cnn.com/brazil-weight-loss-drugs-smuggling-latam-intl
The scientist who took on big pharma, helped save 10 million lives. Now worth $5.25 billion
financialexpress.com/business/news/the-scientist-who-took-on-big-pharma-helped-save-10-million-lives-now-worth-525-billion/4328033/
htmedia.page.link Sep 06
Over 300% rally in five years! Multibagger Pharma stock to be in focus on Monday | Here's why
livemint.com/market/stock-market-news/over-300-rally-in-five-years-multibagger-pharma-stock-sudarshan-pharma-to-be-in-focus-on-monday-heres-why-11788687013896.html
LIV golfer Jon Rahm grilled on future amid 2.0 uncertainty and PGA pathway: Spaniard asked about his future with breakaway circuit ahead of Amgen Irish Open ...
scotsman.com/sport/liv-golfer-jon-rahm-grilled-on-future-amid-20-uncertainty-and-pga-pathway-8988048
Novo Nordisk launches Wegovy weight-loss pill in Germany: Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on ...
reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/
HSE approves reimbursement of Skyclarys for Friedreich’s ataxia patients: Decision reverses recommendation made by HSE Drugs Group two weeks ago
independent.ie/irish-news/health/hse-approves-reimbursement-of-skyclarys-for-friedreichs-ataxia-patients/a/160472149.html
By mid-2026, retatrutide is a known entity. Eli Lilly's triple GLP-1/ GIP/glucagon agonist has now completed all four core TRIUMPH phase 3 trials plus a ... Show more
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
reuters.com/legal/litigation/success-after-century-failures-inside-moderna-mercks-cancer-vaccine-breakthrough-2026-08-28/
defence-blog.com Sep 03
San Diego USV maker says Quickfish has entered production: San Diego-based unmanned surface vessel maker Seasats said its Quickfish interceptor-class USV has ...
defence-blog.com/san-diego-usv-maker-says-quickfish-has-entered-production/
Novartis pauses trials of experimental cell therapy after three deaths: The halt was implemented on August 24 after Novartis was notified of three cases of a ...
thejakartapost.com/culture/2026/09/01/novartis-pauses-trials-of-experimental-cell-therapy-after-three-deaths
htmedia.page.link Aug 28
Tukaram Mundhe-led Maharashtra FDA cancels Cipla unit's drug licence over Reactin Plus irregularities
livemint.com/news/india/tukaram-mundhe-led-maharashtra-fda-cancels-cipla-units-drug-licence-over-reactin-plus-irregularities-11787921799707.html
Merck added billions in a single day after its Moderna-partnered cancer vaccine cleared a major hurdle.
Read more: thestreet.com
Moderna after the mega-rally: Analyst warns: Moderna shares rose sharply after positive cancer studies, but were downgraded to "Sell" by Rothschild & Co ...
deraktionaer.de/artikel/pharma-biotech/moderna-nach-der-mega-rally-analyst-warnt-20408164.html
